Home › Trial NCT00822432
Coproporphyrine Isomers and Methotrexate Elimination
- Trial IDNCT00822432
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorAssistance Publique - Hôpitaux de Paris
- Enrollment85
- Start date2007-10
- ConditionsCentral Nervous System Neoplasms · Lymphoma, Large B-Cell, Diffuse · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma · Burkitt Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.